Glenmede Trust CO Na Igm Biosciences, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $286,384 - $394,780	-4,355 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $10,842 - $18,064	-187 Reduced 4.12%	4,355 $362,000
Q1 2021 May 18, 2021	BUY	$71.56 - $121.23 $122,510 - $207,545	1,712 Added 60.49%	4,542 $348,000
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $80,834 - $196,126	-1,705 Reduced 37.6%	2,830 $249,000
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $119,540 - $233,547	2,780 Added 158.4%	4,535 $334,000
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $90,031 - $131,993	1,755 New	1,755 $128,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.